Infectious Diseases / Neurology

PER Postgame™: Protecting Patients with MS from COVID-19—Exploring the Latest in Prevention and Immunosuppressive Treatment Strategies

CME: 1.25

January 5, 2022
/ Print / Reprints /
| Share More
/ Text Size+

Learning Objectives

Upon successful completion of this activity, you should be better prepared to:

  • Describe the immunological pathways activated by vaccine administration
  • Explain the mechanisms underlying the antiviral efficacy of current SARSCoV-2 vaccines
  • Discuss the impact of disease-modifying therapies (DMTs) on anti-SARS-CoV-2 vaccine response in patients with MS
  • Implement timely, evidence-based strategies for addressing COVID-19 in patients with MS

Post a comment to this article